Delivery Order SPE2DB20D2104-SPE2DB24FS21R
- Not listed
- This federal contract award, valued at $1,437.42, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of March 21, 2025 and is a firm fixed-price delivery order. The contract is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
- This federal contract award, valued at $36,954.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, and has an ultimate completion date of June 6, 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA), a component of the Department of Defense, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,607.94, is a delivery order for JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract has an ultimate completion date of November 30, 2023 and is a firm fixed-price delivery order. The award was not designated with a set-aside...
- This federal contract award, valued at $4,047.57, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a type of pharmaceutical product. This is a Firm Fixed Price Delivery Order contract with a completion date of November 15, 2024. The contract is not designated as a set-aside and was awarded through open competition....
- This federal contract award, valued at $3,889.82, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for the supply of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product, with a completion date of January 29, 2025. The contract has a Firm Fixed Price pricing type and does not utilize a set-aside designation, indicating open competition....
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,252.72, is for the delivery of JANUMET XR 50-1,000 MG TABLET 60S, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of April 17, 2023. The contract is not associated with a set-aside designation....
- This federal contract award, valued at $3,499.46, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a completion date of June 3, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through...
- This federal contract award is a delivery order valued at $13,127.64 issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 100-1,000 MG TABLET 90S, a medication used to treat diabetes. The award has a firm fixed price and an ultimate completion date of July 17, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at...
- This federal contract award, valued at $61,956.56, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of November 26, 2024. The award is not associated with a set-aside program and is part of a larger Indefinite...
- This federal contract award, valued at $11,222.68, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JANUMET XR 50-1,000 MG TABLET 180S, a pharmaceutical product, with a period of performance through January 27, 2025. The contract is a delivery order under an Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FS21RDelivery Order
This federal contract award, valued at $3,612.11, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, a Delivery Order (DO) under DLA's Indefinite Delivery Contract (IDC), covers the provision of JANUMET XR 100-1,000 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of January 25, 2024 and is a Firm Fixed Price (FFP) agreement. The award was made without any set-aside designation, indicating open competition. AmerisourceBergen is a key vendor for federal healthcare programs, particularly within military and veterans' healthcare systems, as evidenced by its significant IDC with the DLA Troop Support Medical, valued at $999,999,999 through November 2026.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.6k | 1/24/24 |